Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Soft Genetics' NextGene; BGI Tech's Ultra Deep De Novo; CLC Bio's Microbial Genome

Premium

SoftGenetics has released version 2.3.2 of its NextGene sequencing analysis software. The release includes applications for copy number variant analysis, HLA analysis, as well as a somatic mutation mining tool that can be used with all available sequencing platforms.


BGI Tech has launched Ultra-Deep De Novo, an assembly algorithm that adopts the firm's SOAPdenovo2 assembly software and heterozygous sequence processing algorithm. The tool classifies heterozygous regions within the genome, following ultra-deep sequencing greater than 200-fold coverage.


CLC Bio has launched CLC Microbial Genome Finishing Module, an add-on module to CLC Genomics Workbench. The module includes tools to align and analyze contigs, collect paired reads statistics, create amplicons and primers, add reads to contigs, sample reads and find sequence, reassemble regions, and extend contigs.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.